Suppression of extrapyramidal side effects of doxepin by thalamic deep brain stimulation for tourettesyndrome

L. Rzesnitzek; T. Wächter; R. Krüger; A. Gharabaghi; C. Plewnia

doi:10.1212/WNL.0b013e318236485f

Suppression of extrapyramidal side effects of doxepin by thalamic deep brain stimulation for tourettesyndrome

L. Rzesnitzek, T. Wächter, R. Krüger, A. Gharabaghi, C. Plewnia^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	1708-1709
Number of pages	2
Journal	Neurology
Volume	77
Issue number	18
DOIs	https://doi.org/10.1212/WNL.0b013e318236485f
Publication status	Published - 1 Nov 2011
Externally published	Yes

Access to Document

10.1212/WNL.0b013e318236485f

Cite this

@article{33323a5b609a473b83614f55c5bc074e,

title = "Suppression of extrapyramidal side effects of doxepin by thalamic deep brain stimulation for tourettesyndrome",

author = "L. Rzesnitzek and T. W{\"a}chter and R. Kr{\"u}ger and A. Gharabaghi and C. Plewnia",

note = "Funding Information: Disclosure: Dr. Rzesnitzek reports no disclosures. Dr. W{\"a}chter has received funding for travel and/or speaker honoraria from Medtronic, Inc., Solvay Pharmaceuticals, Inc./Abbott, and SCHWARZ PHARMA and holds stock/stock options in Gilead Sciences, Inc. Dr. Gharabaghi receives research support from the German Research Council (DFG), the German Ministry for Education and Research (BMBF), Medtronic, Inc., and the European Union. Dr. Kr{\"u}ger has received funding for travel and/or speaker honoraria from UCB, Cephalon, Inc., Abbott, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Medtronic, Inc.; serves as an Associate Editor for the European Journal of Clinical Investigations, the Journal of Neural Transmission, and BMC Neurology; and receives research support from the German Research Council (DFG), and the Federal Ministry for Education and Research (BMBF). Dr. Plewnia has received speaker honoraria from inomed Medizintechnik GmbH and Deutsche Tinnitus Liga and receives research support from inomed Medizintechnik GmbH, Northstar Neuroscience, and the German Research Council (DFG). Funding Information: Study funding: This collaborative work of the T{\"u}bingen Brain Stimulation Network (T{\"u}bingen BrainStimNet) was supported by a grant from the University of T{\"u}bingen (AKF 238–0-0) . ",

year = "2011",

month = nov,

day = "1",

doi = "10.1212/WNL.0b013e318236485f",

language = "English",

volume = "77",

pages = "1708--1709",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "18",

}

TY - JOUR

T1 - Suppression of extrapyramidal side effects of doxepin by thalamic deep brain stimulation for tourettesyndrome

AU - Rzesnitzek, L.

AU - Wächter, T.

AU - Krüger, R.

AU - Gharabaghi, A.

AU - Plewnia, C.

N1 - Funding Information: Disclosure: Dr. Rzesnitzek reports no disclosures. Dr. Wächter has received funding for travel and/or speaker honoraria from Medtronic, Inc., Solvay Pharmaceuticals, Inc./Abbott, and SCHWARZ PHARMA and holds stock/stock options in Gilead Sciences, Inc. Dr. Gharabaghi receives research support from the German Research Council (DFG), the German Ministry for Education and Research (BMBF), Medtronic, Inc., and the European Union. Dr. Krüger has received funding for travel and/or speaker honoraria from UCB, Cephalon, Inc., Abbott, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Medtronic, Inc.; serves as an Associate Editor for the European Journal of Clinical Investigations, the Journal of Neural Transmission, and BMC Neurology; and receives research support from the German Research Council (DFG), and the Federal Ministry for Education and Research (BMBF). Dr. Plewnia has received speaker honoraria from inomed Medizintechnik GmbH and Deutsche Tinnitus Liga and receives research support from inomed Medizintechnik GmbH, Northstar Neuroscience, and the German Research Council (DFG). Funding Information: Study funding: This collaborative work of the Tübingen Brain Stimulation Network (Tübingen BrainStimNet) was supported by a grant from the University of Tübingen (AKF 238–0-0) .

PY - 2011/11/1

Y1 - 2011/11/1

UR - http://www.scopus.com/inward/record.url?scp=82955210349&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e318236485f

DO - 10.1212/WNL.0b013e318236485f

M3 - Article

AN - SCOPUS:82955210349

SN - 0028-3878

VL - 77

SP - 1708

EP - 1709

JO - Neurology

JF - Neurology

IS - 18

ER -

Suppression of extrapyramidal side effects of doxepin by thalamic deep brain stimulation for tourettesyndrome

Access to Document

Other files and links

Cite this